353 related articles for article (PubMed ID: 23515552)
1. Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131.
Birgy A; Mariani-Kurkdjian P; Bidet P; Doit C; Genel N; Courroux C; Arlet G; Bingen E
J Clin Microbiol; 2013 Jun; 51(6):1727-32. PubMed ID: 23515552
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.
Johnson JR; Urban C; Weissman SJ; Jorgensen JH; Lewis JS; Hansen G; Edelstein PH; Robicsek A; Cleary T; Adachi J; Paterson D; Quinn J; Hanson ND; Johnston BD; Clabots C; Kuskowski MA;
Antimicrob Agents Chemother; 2012 May; 56(5):2364-70. PubMed ID: 22354301
[TBL] [Abstract][Full Text] [Related]
4. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
Peirano G; Costello M; Pitout JD
Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15.
Park SH; Byun JH; Choi SM; Lee DG; Kim SH; Kwon JC; Park C; Choi JH; Yoo JH
BMC Infect Dis; 2012 Jun; 12():149. PubMed ID: 22747570
[TBL] [Abstract][Full Text] [Related]
6. Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes.
Brisse S; Diancourt L; Laouénan C; Vigan M; Caro V; Arlet G; Drieux L; Leflon-Guibout V; Mentré F; Jarlier V; Nicolas-Chanoine MH;
J Clin Microbiol; 2012 Sep; 50(9):2974-81. PubMed ID: 22760036
[TBL] [Abstract][Full Text] [Related]
7. Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics.
Blanco J; Mora A; Mamani R; López C; Blanco M; Dahbi G; Herrera A; Marzoa J; Fernández V; de la Cruz F; Martínez-Martínez L; Alonso MP; Nicolas-Chanoine MH; Johnson JR; Johnston B; López-Cerero L; Pascual A; Rodríguez-Baño J;
J Clin Microbiol; 2013 Oct; 51(10):3358-67. PubMed ID: 23926164
[TBL] [Abstract][Full Text] [Related]
8. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131.
Al-Agamy MH; Shibl AM; Hafez MM; Al-Ahdal MN; Memish ZA; Khubnani H
Ann Clin Microbiol Antimicrob; 2014 Jan; 13():4. PubMed ID: 24397567
[TBL] [Abstract][Full Text] [Related]
9. The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.
Price LB; Johnson JR; Aziz M; Clabots C; Johnston B; Tchesnokova V; Nordstrom L; Billig M; Chattopadhyay S; Stegger M; Andersen PS; Pearson T; Riddell K; Rogers P; Scholes D; Kahl B; Keim P; Sokurenko EV
mBio; 2013 Dec; 4(6):e00377-13. PubMed ID: 24345742
[TBL] [Abstract][Full Text] [Related]
10. Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China.
Zhong YM; Liu WE; Liang XH; Li YM; Jian ZJ; Hawkey PM
J Antimicrob Chemother; 2015 Aug; 70(8):2223-7. PubMed ID: 25957581
[TBL] [Abstract][Full Text] [Related]
11. Trends of extended-spectrum β-lactamase-producing Escherichia coli sequence type 131 and its H30 subclone in a French hospital over a 15-year period.
Sauget M; Cholley P; Vannier A; Thouverez M; Nicolas-Chanoine MH; Hocquet D; Bertrand X
Int J Antimicrob Agents; 2016 Dec; 48(6):744-747. PubMed ID: 27836379
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains.
Blanc V; Leflon-Guibout V; Blanco J; Haenni M; Madec JY; Rafignon G; Bruno P; Mora A; Lopez C; Dahbi G; Dunais B; Anastay M; Branger C; Moreau R; Pradier C; Nicolas-Chanoine MH
J Antimicrob Chemother; 2014 May; 69(5):1231-7. PubMed ID: 24402502
[TBL] [Abstract][Full Text] [Related]
13. CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.
Merino I; Shaw E; Horcajada JP; Cercenado E; Mirelis B; Pallarés MA; Gómez J; Xercavins M; Martínez-Martínez L; De Cueto M; Cantón R; Ruiz-Garbajosa P;
J Antimicrob Chemother; 2016 Aug; 71(8):2125-30. PubMed ID: 27494832
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark.
Olesen B; Hansen DS; Nilsson F; Frimodt-Møller J; Leihof RF; Struve C; Scheutz F; Johnston B; Krogfelt KA; Johnson JR
J Clin Microbiol; 2013 Jun; 51(6):1779-85. PubMed ID: 23554186
[TBL] [Abstract][Full Text] [Related]
15. The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel.
Karfunkel D; Carmeli Y; Chmelnitsky I; Kotlovsky T; Navon-Venezia S
Eur J Clin Microbiol Infect Dis; 2013 Apr; 32(4):513-21. PubMed ID: 23117265
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of O25b-ST131 clone among Escherichia coli strains producing CTX-M-15, CTX-M-14 and CTX-M-92 β-lactamases.
Giedraitienė A; Vitkauskienė A; Pavilonis A; Patamsytė V; Genel N; Decre D; Arlet G
Infect Dis (Lond); 2017 Feb; 49(2):106-112. PubMed ID: 27563748
[TBL] [Abstract][Full Text] [Related]
17. Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals.
Zhang J; Zheng B; Zhao L; Wei Z; Ji J; Li L; Xiao Y
BMC Infect Dis; 2014 Dec; 14():659. PubMed ID: 25466590
[TBL] [Abstract][Full Text] [Related]
18. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.
Yumuk Z; Afacan G; Nicolas-Chanoine MH; Sotto A; Lavigne JP
J Antimicrob Chemother; 2008 Aug; 62(2):284-8. PubMed ID: 18453527
[TBL] [Abstract][Full Text] [Related]
19. First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran.
Namaei MH; Yousefi M; Ziaee M; Salehabadi A; Ghannadkafi M; Amini E; Askari P
Microb Drug Resist; 2017 Oct; 23(7):879-884. PubMed ID: 28437226
[TBL] [Abstract][Full Text] [Related]
20. Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections.
Pitout JD; Gregson DB; Campbell L; Laupland KB
Antimicrob Agents Chemother; 2009 Jul; 53(7):2846-51. PubMed ID: 19380595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
